Glucotrack to present at 2024 biofuture conference

Continuous blood glucose monitor to be among 100+ future-focused presentations at industry investor conference rutherford, nj, oct. 22, 2024 (globe newswire) -- glucotrack, inc. (nasdaq: gctk) (“glucotrack” or the “company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it will participate in the 2024 biofuture conference, to be held at cure in new york city from october 28-30, 2024. paul v. goode, president & chief executive officer of glucotrack, will present on tuesday, october 29, 2024, at 11:00 am et and will hold one-on-one meetings.
GCTK Ratings Summary
GCTK Quant Ranking